Andreas Straub

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor

Elisabeth Perzborn, Andreas Wilmen, Jens Pohlmann et al. · Journal of Thrombosis and Haemostasis · 2005 · 584 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Outcomes of a Delirium Prevention Program in Older Persons After Elective Surgery

Friederike Deeken, Alba Sánchez, Michael A. Rapp et al. · JAMA Surgery · 2021 · 147 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood

Stefanie Krajewski, Robert Prucek, Aleš Panáček et al. · Acta Biomaterialia · 2013 · 134 citations

Natural Sciences, Hematology, Materials Science +11

Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Jan David Hohmann, Xiaowei Wang, Stefanie Krajewski et al. · Blood · 2013 · 82 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Evidence of Platelet Activation at Medically Used Hypothermia and Mechanistic Data Indicating ADP as a Key Mediator and Therapeutic Target

Andreas Straub, Stefanie Krajewski, Jan David Hohmann et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 82 citations · Full text

Medicine, Hematology, Pharmacology +17